Tune in to hear PwC specialists discuss their recently published article: How a local-first strategy in China can help global pharma and life sciences players reduce risk and drive growth. Topics include:

Sharing key strategies for pharma companies contemplating localization in China, offering valuable insights on maximizing business growth while mitigating risks in the Chinese market
Three approaches organizations can consider to competing at a local level in China
Impacts to different functions across the value chain such as R&D, supply chain, and IT

Speakers:
Nalneesh Gaur, Partner, Pharmaceutical and Life Sciences Cybersecurity, PwC
Ben Rhee, Principal, Pharmaceutical and Life Sciences Enterprise Strategy and Value, PwC
Igor Belokrinitsky, Strategy& Principal, PwC

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Key strategies for global pharma compani...